Dr Reddy’s delays Semaglutide supplies after API quality issue

India's Dr Reddy's sees semaglutide supply disruption lasting until at least late October

Independent US body finds drug shortages are lasting longer as reliability dwindles

Inside the Grey Market Peptide Economy: Regulatory Gaps and Underground Pharmaceutical Infrastructure

This article investigates the parallel pharmaceutical infrastructure built around grey market peptides like BPC-157 and semaglutide. It cont

Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy

India’s Generic Pharma Industry Is Sitting on a Formulation Data Time Bomb

Drug pricing in Canada